Day: November 25, 2020

CALGARY, Alberta, 25 nov. 2020 (GLOBE NEWSWIRE) — Le fonds Canoe EIT Income Fund (« Canoe » ou le « fonds »), [Bourse de Toronto : EIT.UN] a annoncé aujourd’hui les résultats du rachat volontaire en argent pour 2020.Des demandes de rachat d’environ 68,863 de parts du fonds, ce qui représente environ 0,06 % des parts émises et en circulation, ont été présentées par les porteurs de parts. La déclaration de fiducie du fonds limite le nombre de parts rachetées dans le cadre du rachat annuel à 10 % des parts émises et en circulation à la dernière journée pour présenter les demandes de rachat, soit le 17 novembre 2020. Le produit du rachat sera versé aux alentours du 4 janvier 2021 à un prix de rachat équivalent à 95 % de la valeur liquidative moyenne par part, établie en fonction des trois jours ouvrables précédant la date...

This news release should be read in conjunction with Amarillo Gold Corporation’s condensed interim consolidated financial statements and management’s discussion and analysis for the nine months ended September 30, 2020. Both are available at www.amarillogold.com and filed under the Company’s profile on SEDAR at www.sedar.com.All monetary amounts are expressed in Canadian dollars unless otherwise specified.TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Amarillo Gold Corporation (Amarillo or the Company) (TSXV: AGC, OTCQB: AGCBF) today announced its financial results for the nine months ended September 30, 2020.During the third quarter of 2020, Amarillo continued to prepare to break ground on the Posse Gold Mine. It recruited two mine builders with experience in Brazil to the board of directors, placed orders for long lead time items,...

MONTRÉAL, 25 nov. 2020 (GLOBE NEWSWIRE) — Redevances Aurifères Osisko Ltée (« Redevances Osisko ») (TSX et NYSE : OR) et Osisko Développement Corp. (« Osisko Développement ») (TSX-V : ODV) ont le plaisir d’annoncer le lancement d’Osisko Développement – une société de développement aurifère de premier plan en Amérique du Nord ayant pour objectif de devenir le prochain producteur aurifère intermédiaire. Les actions ordinaires d’Osisko Développement (les « actions ODV ») commenceront à être négociées sur la Bourse de croissance TSX le ou vers le 2 décembre sous le symbole « ODV ».Clôture de la PCIPlus tôt aujourd’hui, Redevances Osisko et Osisko Développement ont complété leur transaction de transfert d’actifs précédemment annoncée, laquelle s’est traduite, entre autres, par le transfert par Redevances Osisko de certaines propriétés...

WINNIPEG, Manitoba, Nov. 25, 2020 (GLOBE NEWSWIRE) — Empire Industries Ltd. (TSX-V: EIL) (“Empire” or the “Company”) today announced changes to the composition of its board of directors, arising from its Annual General and Special Meeting of Shareholders held yesterday.“I am pleased to welcome our new director, Guy Dietrich, to the Board,” said Guy Nelson, Executive Chairman and Chief Executive Officer. “Mr. Dietrich’s skills and experience in financing will provide the Board with significant depth as we continue our transition to a recurring revenue co-venture business model.”Mr. Dietrich is a Senior Advisor to Rockefeller Capital Management, after having served as its Managing Director since June 2018. Prior to that, he has 35 years of experience serving as Managing Director in Wealth Management at UBS and Morgan Stanley. Mr....

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) 40mg/10ml. DANYELZA is indicated, in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy. This indication is approved under accelerated approval regulation based on overall...

NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) — FirstMark Horizon Acquisition Corp. (NYSE: FMAC.U) (the “Company”) today announced that, commencing November 27, 2020, holders of the units sold in the Company’s initial public offering of 41,400,000 units completed on October 8, 2020, may elect to separately trade the shares of Class A common stock and redeemable warrants included in the units. Those units not separated will continue to trade on the New York Stock Exchange (“NYSE”) under the symbol “FMAC.U,” and the shares of Class A common stock and redeemable warrants that are separated will trade on NYSE under the symbols “FMAC” and “FMAC WS,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock...